Scientists have been working on a new marker called follicle-stimulating hormone (FSH). It has been found in a study that this marker turns up in many different types of tumours such as prostate, breast, lung and liver cancers.
“Kairbaan Hodivala-Dilke at Barts and The London School of Medicine and Dentistry’s Institute of Cancer agrees: “It’s certainly a good marker, and could be especially useful in surgery, which is a bit hit-and-miss at the moment,” she says. Using colour-labelled antibodies to highlight the edges of a tumour could enable surgeons to “cut along the dotted line”.”
via Universal cancer marker shows new treatment options – health – 20 October 2010 – New Scientist.
Advertisements
